Krebs Biochemicals & Industries Limited

BSE:524518 Stock Report

Market Cap: ₹2.2b

Krebs Biochemicals & Industries Management

Management criteria checks 2/4

Krebs Biochemicals & Industries' CEO is Jitendra Shah, appointed in Aug 2023, has a tenure of 1.33 years. directly owns 0% of the company’s shares, worth ₹9.89K. The average tenure of the management team and the board of directors is 1.3 years and 9.6 years respectively.

Key information

Jitendra Shah

Chief executive officer

₹1.9m

Total compensation

CEO salary percentagen/a
CEO tenure1.3yrs
CEO ownership0.0005%
Management average tenure1.3yrs
Board average tenure9.6yrs

Recent management updates

Recent updates

CEO

Jitendra Shah (56 yo)

1.3yrs

Tenure

₹1,945,000

Compensation

Mr. Jitendra Rameshchandra Shah serves as an Executive Director of Krebs Biochemicals & Industries Limited since August 10, 2023 and served its Additional Non-Executive Director of Krebs Biochemicals & Ind...

Leadership Team

NamePositionTenureCompensationOwnership
Jitendra Shah
MD, CEO & Director1.3yrs₹1.95m0.00046%
₹ 9.9k
Ritesh Jain
Chief Financial Officer1.8yrsno datano data
Rakesh Kalbate
Company Secretary & Compliance Officerless than a yearno datano data

1.3yrs

Average Tenure

Experienced Management: 524518's management team is not considered experienced ( 1.3 years average tenure), which suggests a new team.

Board Members

NamePositionTenureCompensationOwnership
Jitendra Shah
MD, CEO & Director3.1yrs₹1.95m0.00046%
₹ 9.9k
Ravi Tagore
Non-Executive Chairman32.2yrs₹70.00k0.11%
₹ 2.3m
Gundapaneni Venkata Prasad
Independent Non-Executive Director20.3yrs₹90.00k0.66%
₹ 14.2m
Avinash Ravi
Non-Executive Director15.8yrs₹55.00k9.93%
₹ 213.5m
Pabitra Kumar Bhattacharya
Non-Executive Director3.4yrs₹1.10m0.000020%
₹ 430.1
Satish Khivsara
Independent Non-Executive Director9.3yrs₹110.00k0.0049%
₹ 104.7k
Malati Tangirala
Independent Non-Executive Director9.8yrs₹90.00kno data
Raj Kamal Verma
Independent Non-Executive Director8.8yrs₹45.00k0.00097%
₹ 20.9k

9.6yrs

Average Tenure

71yo

Average Age

Experienced Board: 524518's board of directors are considered experienced (9.6 years average tenure).

Company Analysis and Financial Data Status

DataLast Updated (UTC time)
Company Analysis2024/12/24 13:27
End of Day Share Price 2024/12/24 00:00
Earnings2024/09/30
Annual Earnings2024/03/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

PackageDataTimeframeExample US Source *
Company Financials10 years
  • Income statement
  • Cash flow statement
  • Balance sheet
Analyst Consensus Estimates+3 years
  • Forecast financials
  • Analyst price targets
Market Prices30 years
  • Stock prices
  • Dividends, Splits and Actions
Ownership10 years
  • Top shareholders
  • Insider trading
Management10 years
  • Leadership team
  • Board of directors
Key Developments10 years
  • Company announcements

* example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .

Analyst Sources

Krebs Biochemicals & Industries Limited is covered by 0 analysts. 0 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

AnalystInstitution